Published in Am J Trop Med Hyg on October 01, 2013
Cholera Transmission in Ouest Department of Haiti: Dynamic Modeling and the Future of the Epidemic. PLoS Negl Trop Dis (2015) 1.45
Using mobile phone data to predict the spatial spread of cholera. Sci Rep (2015) 1.10
Predictors of disease severity in patients admitted to a cholera treatment center in urban Haiti. Am J Trop Med Hyg (2013) 1.04
Identifying the most sensitive and specific sign and symptom combinations for cholera: results from an analysis of laboratory-based surveillance data from Haiti, 2012-2013. Am J Trop Med Hyg (2015) 0.93
Strategies to Prevent Cholera Introduction during International Personnel Deployments: A Computational Modeling Analysis Based on the 2010 Haiti Outbreak. PLoS Med (2016) 0.90
Spectrum of outpatient illness in a school-based cohort in Haiti, with a focus on diarrheal pathogens. Am J Trop Med Hyg (2015) 0.89
Geographic distribution and mortality risk factors during the cholera outbreak in a rural region of Haiti, 2010-2011. PLoS Negl Trop Dis (2015) 0.83
Development of a cholera vaccination policy on the Island of Hispaniola, 2010-2013. Am J Trop Med Hyg (2013) 0.80
Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults. PLoS Negl Trop Dis (2016) 0.77
Cholera elimination in Hispaniola. Am J Trop Med Hyg (2013) 0.75
Antimicrobial Resistance Risks of Cholera Prophylaxis for United Nations Peacekeepers. Antimicrob Agents Chemother (2017) 0.75
Cholera. Lancet (2004) 10.22
Evolution of new variants of Vibrio cholerae O1. Trends Microbiol (2009) 3.75
Understanding the cholera epidemic, Haiti. Emerg Infect Dis (2011) 3.57
Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. J Infect Dis (1982) 3.28
Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994? Goma Epidemiology Group. Lancet (1995) 3.27
Cholera surveillance during the Haiti epidemic--the first 2 years. N Engl J Med (2013) 3.19
Hyperinfectivity: a critical element in the ability of V. cholerae to cause epidemics? PLoS Med (2005) 2.98
Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J Infect Dis (1985) 2.78
El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect (2009) 2.60
Comparative genomics of Vibrio cholerae from Haiti, Asia, and Africa. Emerg Infect Dis (2011) 2.50
Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol (1985) 2.49
Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop Dis (2008) 2.48
Characterization of toxigenic Vibrio cholerae from Haiti, 2010-2011. Emerg Infect Dis (2011) 2.08
Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun (2005) 1.79
Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes. Hybridoma (1984) 1.67
The ABO blood group system and Plasmodium falciparum malaria. Blood (2007) 1.66
Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun (2009) 1.56
Cholera toxin production by the El Tor variant of Vibrio cholerae O1 compared to prototype El Tor and classical biotypes. J Clin Microbiol (2010) 1.56
Cholera in Haiti and other Caribbean regions, 19th century. Emerg Infect Dis (2011) 1.48
Seroepidemiologic studies during a simultaneous epidemic of infection with El Tor Ogawa and classical Inaba Vibrio cholerae. J Infect Dis (1970) 1.40
Severe life-threatening cholera associated with blood group O in Peru: implications for the Latin American epidemic. J Infect Dis (1994) 1.19
Cholera in the Americas. Guidelines for the clinician. JAMA (1992) 1.10
Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology. Am J Epidemiol (1981) 1.08
Nutritional status: a determinant of severity of diarrhea in patients with cholera. J Infect Dis (1976) 1.08
Cholera in the United States, 1995-2000: trends at the end of the twentieth century. J Infect Dis (2001) 1.08
Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial. BMJ (2008) 1.08
Cholera, non-vibrio cholera, and stomach acid. Lancet (1978) 1.07
Notes from the field: Identification of Vibrio cholerae serogroup O1, serotype Inaba, biotype El Tor strain - Haiti, March 2012. MMWR Morb Mortal Wkly Rep (2012) 1.03
Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine. Pediatr Infect Dis J (1989) 0.88
Low gastric acid as a risk factor for cholera transmission: application of a new non-invasive gastric acid field test. J Clin Epidemiol (1990) 0.87
The spectrum of cholera in rural East Pakistan. I. Correlation of bacteriologic and serologic results. J Infect Dis (1970) 0.81
Cholera deaths in Goma. Lancet (1995) 0.79
Serum ferritin and cholera. A prospective study. Trop Geogr Med (1992) 0.78
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med (2012) 27.84
A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science (2007) 18.96
The global burden of typhoid fever. Bull World Health Organ (2004) 14.14
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet (2013) 14.06
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis (2006) 7.98
Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev (2004) 7.51
Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog (2008) 6.07
Global trends in typhoid and paratyphoid Fever. Clin Infect Dis (2010) 5.25
Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog (2009) 4.56
Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet (2009) 4.33
The epidemiology of human listeriosis. Microbes Infect (2007) 4.10
The effectiveness of worksite nutrition and physical activity interventions for controlling employee overweight and obesity: a systematic review. Am J Prev Med (2009) 3.84
Understanding the cholera epidemic, Haiti. Emerg Infect Dis (2011) 3.57
Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep (2009) 3.33
Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis (2002) 3.32
Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. PLoS One (2011) 3.27
Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med (2012) 3.26
Mental health problems among adults in tsunami-affected areas in southern Thailand. JAMA (2006) 3.25
Cholera surveillance during the Haiti epidemic--the first 2 years. N Engl J Med (2013) 3.19
Short and long term mortality associated with foodborne bacterial gastrointestinal infections: registry based study. BMJ (2003) 3.03
The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis (2012) 2.70
Evidence of a previously undocumented epidemic of HIV infection among men who have sex with men in Bangkok, Thailand. AIDS (2005) 2.58
Comparative genomics of Vibrio cholerae from Haiti, Asia, and Africa. Emerg Infect Dis (2011) 2.50
Virulence factors for hemolytic uremic syndrome, Denmark. Emerg Infect Dis (2004) 2.40
Venous thromboembolism: a public health concern. Am J Prev Med (2010) 2.37
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. Clin Infect Dis (2009) 2.36
Multidrug-resistant typhoid fever with neurologic findings on the Malawi-Mozambique border. Clin Infect Dis (2012) 2.32
Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest (2007) 2.27
Evolutionary dynamics of Vibrio cholerae O1 following a single-source introduction to Haiti. MBio (2013) 2.24
Postpartum venous thromboembolism: incidence and risk factors. Obstet Gynecol (2014) 2.21
Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening. Transfusion (2012) 2.19
Is structured observation a valid technique to measure handwashing behavior? Use of acceleration sensors embedded in soap to assess reactivity to structured observation. Am J Trop Med Hyg (2010) 2.17
Evaluation of rapid diagnostic tests for typhoid fever. J Clin Microbiol (2004) 2.15
Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. Antimicrob Agents Chemother (2008) 2.14
The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention. J Invasive Cardiol (2010) 2.10
Characterization of toxigenic Vibrio cholerae from Haiti, 2010-2011. Emerg Infect Dis (2011) 2.08
A waterborne outbreak of gastroenteritis with multiple etiologies among resort island visitors and residents: Ohio, 2004. Clin Infect Dis (2007) 2.07
Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand. J Acquir Immune Defic Syndr (2008) 2.05
Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand. Emerg Infect Dis (2007) 2.04
Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008. Am J Obstet Gynecol (2012) 2.03
Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis (2002) 2.02
Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis (2005) 2.02
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00
Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog (2012) 2.00
HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect Dis (2009) 2.00
Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa. PLoS One (2012) 1.99
Symptoms of posttraumatic stress disorder and depression among children in tsunami-affected areas in southern Thailand. JAMA (2006) 1.98
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ (2011) 1.96
Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana. Clin Infect Dis (2005) 1.95
Sickle cell trait and the risk of venous thromboembolism among blacks. Blood (2007) 1.95
Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease. Clin Infect Dis (2006) 1.92
Elimination of cholera transmission in Haiti and the Dominican Republic. Lancet (2012) 1.91
Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis (2012) 1.91
Etiology of diarrhea in young children in Denmark: a case-control study. J Clin Microbiol (2005) 1.89
Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995-1998. Emerg Infect Dis (2002) 1.89
Salmonella control programs in Denmark. Emerg Infect Dis (2003) 1.86
Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics (2007) 1.85
Cholera: a new homeland in Africa? Am J Trop Med Hyg (2007) 1.83
HIV infection among men who have sex with men in Kampala, Uganda--a respondent driven sampling survey. PLoS One (2012) 1.79
Interpretation of pulsed-field gel electrophoresis patterns in foodborne disease investigations and surveillance. Foodborne Pathog Dis (2006) 1.79
Fresh chicken as main risk factor for campylobacteriosis, Denmark. Emerg Infect Dis (2006) 1.77
Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg Infect Dis (2010) 1.75
Palmtop-assisted self-interviewing for the collection of sensitive behavioral data: randomized trial with drug use urine testing. Am J Epidemiol (2005) 1.72
Climate variability and campylobacter infection: an international study. Int J Biometeorol (2004) 1.69
HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay. AIDS Res Hum Retroviruses (2003) 1.68
Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011. Emerg Infect Dis (2011) 1.68
Acceptability of Carraguard vaginal gel use among Thai couples. AIDS (2006) 1.65
High mortality in a cholera outbreak in western Kenya after post-election violence in 2008. Am J Trop Med Hyg (2009) 1.64
Epidemic diarrhea due to enterotoxigenic Escherichia coli. Clin Infect Dis (2005) 1.63
Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke (2002) 1.63
Multidrug-resistant tuberculosis outbreak among US-bound Hmong refugees, Thailand, 2005. Emerg Infect Dis (2008) 1.62
Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial. BMJ (2011) 1.62
Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae. J Clin Microbiol (2002) 1.61
Building PulseNet International: an interconnected system of laboratory networks to facilitate timely public health recognition and response to foodborne disease outbreaks and emerging foodborne diseases. Foodborne Pathog Dis (2006) 1.59
The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol (2006) 1.59
Laboratory-confirmed shigellosis in the United States, 1989-2002: epidemiologic trends and patterns. Clin Infect Dis (2004) 1.56
Drug-resistance mechanisms in Vibrio cholerae O1 outbreak strain, Haiti, 2010. Emerg Infect Dis (2011) 1.54
Trends in in-hospital deaths among hospitalizations with pulmonary embolism. Arch Intern Med (2012) 1.53
Public health in Haiti--challenges and progress. N Engl J Med (2011) 1.53
Risk factors for diarrhea among children in an industrialized country. Epidemiology (2006) 1.51
Planning against biological terrorism: lessons from outbreak investigations. Emerg Infect Dis (2003) 1.51
Novel virulence gene and clustered regularly interspaced short palindromic repeat (CRISPR) multilocus sequence typing scheme for subtyping of the major serovars of Salmonella enterica subsp. enterica. Appl Environ Microbiol (2011) 1.51
Vaccination for typhoid fever in sub-Saharan Africa. Hum Vaccin Immunother (2013) 1.50
Household effects of school closure during pandemic (H1N1) 2009, Pennsylvania, USA. Emerg Infect Dis (2010) 1.49
Antimicrobial treatment of asymptomatic carriers of verocytotoxin-producing Escherichia coli: an empiric study. Scand J Infect Dis (2005) 1.48
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis (2012) 1.45
Integrating genome-based informatics to modernize global disease monitoring, information sharing, and response. Emerg Infect Dis (2012) 1.45
Respondent-driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand. Drug Alcohol Depend (2007) 1.43
Spatio-temporal dynamics of cholera during the first year of the epidemic in Haiti. PLoS Negl Trop Dis (2013) 1.42
Accumulation of retained nonfunctional arteriovenous grafts correlates with severity of inflammation in asymptomatic ESRD patients. Nephrol Dial Transplant (2012) 1.41
Hepatitis E epidemic, Uganda. Emerg Infect Dis (2010) 1.41
HIV prevalence, risk behavior, hormone use and surgical history among transgender persons in Thailand. AIDS Behav (2011) 1.40
[Excess mortality associated with antibiotic resistant Salmonella typhimurium]. Ugeskr Laeger (2003) 1.40